Osteo Science Foundation was established in 2013 by Dr. Peter Geistlich and Geistlich Pharma, a global leader in regenerative medicine for dental and oral-maxillofacial surgery. Dr. Geistlich, former Chairman of the Board of Directors of Geistlich Pharma, is recognized worldwide as a pioneer and innovator in biomaterials research and development, and it is because of his vision and dedication that Osteo Science Foundation became a reality.
Dr. Geistlich and his colleague and close friend, Dr. Philip Boyne, then Professor at Loma Linda University, initially conceived the creation of a U.S. Foundation in 2007 to support regenerative medicine in oral, cranial and maxillofacial surgery. Their shared vision was to provide a platform for scientific studies and the exchange of ideas in regenerative medicine. Further, they wanted a channel by which to support the next generation of clinicians and to bring together clinical research with industry in Oral and CranioMaxillofacial Surgery.
Dr. Geistlich and Geistlich Pharma formally launched Osteo Science Foundation in honor of Dr. Boyne’s surgical excellence, outstanding research, and to make his vision of bone and tissue regeneration a reality.
Though Doctors Geistlich and Boyne are no longer with us, Osteo Science Foundation is proud to continue their work. Both doctors are among the true pioneers of research and education in tissue regeneration, and today, the Foundation remains steadfast in its pursuit to build upon their legacies and to shape the future of regenerative medicine.
In 2019, Osteo Science Foundation announced plans to expand the reach of the organization to an international audience. While initially established to serve a North American population, it became apparent that the activities of the foundation could benefit the larger Oral and CranioMaxillofacial Community. To that end, research and education programs are being developed to serve surgeons both inside and outside our initial geographical scope. This exciting endeavor allows the foundation to more significantly contribute to the area of regenerative medicine in OMFS.
It is with deep sadness that we mourn the passing of our founder: a unique person, pioneering entrepreneur and visionary whose dedication to regenerative medicine led to the creation of the Osteo Science Foundation. For over 60 years, Dr. Peter Geistlich creatively and tirelessly broke new ground at Geistlich, a family-based company that was founded in 1851 in Switzerland.
In the 1980s he initiated the company’s entry into medical technology with the development of bone regeneration products. Geistlich Pharma, which Dr. Geistlich presided over since its inception, has today established itself as the global market leader in oral tissue regeneration. Dr. Geistlich also held strong interests in orthopaedics and oncology.
Science was his life. The Osteo Science Foundation, launched by Dr. Geistlich in October 2013, will continue to realize his vision of research and education, as well as cooperation between industry and academia, in the field of regeneration. The work of the Foundation will be his legacy to the future of regenerative medicine in the field.
Dr. Peter Geistlich will remain an inspiration for the Osteo Science Foundation. We extend our most sincere condolences to his wife and family.
Dr. Ing. chem. ETH
May 8, 1927 – July 23, 2014
Board of Directors, Executive Committee and Staff
Geistlich Pharma AG, Bahnhofstrasse 40, 6110 Wolhusen
Ed. Geistlich Söhne AG, Engstringerstrasse 5, 8952 Schlieren
Osteology Foundation, Landenbergstrasse 35, 6002 Lucerne
Osteo Science Foundation, 1650 Market Street, Philadelphia, PA
Dr. Philip Boyne was a world-renowned oral and maxillofacial surgeon, dental implantologist, biological innovator, and bone physiologist. Osteo Science Foundation was established, in part, to honor Dr. Boyne and his surgical excellence and outstanding research and to make his vision of bone and tissue regeneration a reality.
A native of Maine, Dr. Boyne received his BA degree from Colby College. After receiving a DMD degree from Tufts School of Dental Medicine and an MS degree in Bone Grafting from Georgetown University, he joined the U.S. Navy as a lieutenant and completed landmark research in the study of bone.
Dr. Boyne’s 20 years of service included active duty in Vietnam as a surgeon on an aircraft carrier, followed by intensive studies of severe craniomaxillary injuries sustained in battle. He wrote the roadmap for facial skeletal reconstruction that still serves as a fundamental guide to surgeons.
Upon retirement with a rank of captain from the Navy, he served on the faculty at the University of California at Los Angeles where he was Assistant Dean for Graduate Training and Hospital Affairs. After serving as Founding Dean of the new School of Dentistry at the University of Texas, San Antonio, he was appointed to the faculty of Loma Linda University Medical Center as Chief of the Oral and Maxillofacial Service. He was made Professor Emeritus in 2001.
Dr. Boyne’s work involved a lifelong study of maxillofacial bone grafting. He was the first to develop and report many new surgical procedures including the use of hyperbaric oxygen to treat bone infection of the jaws, the use of membranes to guide bone repair, and the use of an effective autogenous graft system to correct cleft palate deformities. Later, his research involved the application of bone inductor cytokines to produce bone repair without the necessity of bone grafting.
Other remarkable firsts in dental treatment are attributed to Dr. Boyne. He studied the use of xenograft, freezedried bone, and autograft for bone defect treatment more than 50 years ago. He advocated the use of autogenous bone marrow aspirate in dental reconstruction, and reported the first verified technique for secondary bone grafting of alveolar clefts. He was the first to describe use of sinus elevation to augment alveolar bone mass for implants. In 1987, he reported the use of socket preservation grafts. He is credited with initial use of human bone morphogenetic protein-2 for mandibular discontinuity treatment, for sinus grafting, for cleft repair, and as part of dental implant surfaces.
For his pioneering development of a method of cleft palate grafting now used internationally, he was the recipient of the highest honor given by the American Cleft Palate-Craniofacial Association, the “Honors of the Association.” Dr. Boyne also received the Distinguished Alumnus Award from Colby College and the Distinguished Faculty Award from Loma Linda University School of Dentistry. He served as examiner for the American Board of Oral and Maxillofacial Surgery for 14 years and served as president of that Board. In addition to being president of the American Board of OMFS, Dr. Boyne served as president of the American College of OMFS and as president of the American Institute of Oral Biology.
Notable among his accomplishments is his influence on students and colleagues. Alan Herford, DDS, MD, the Founding Board Member of Osteo Science Foundation, participated with Dr. Boyne in research. He said of Dr. Boyne, “Dr. Boyne was the reason I chose to pursue a career in oral and maxillofacial surgery. When I completed a residency program in 2000, I chose to return to Loma Linda—a big reason was to work with Dr. Boyne, whom I first got to know as a dental student working on various research projects with him. He has been a mentor, colleague, and friend, but mostly, an inspiration. We discussed topics ranging from surgery to baseball. I have many fond memories of spending time with both him and Mrs. Boyne. I continually asked for his advice and guidance. I owe much of what I have become as an OMF surgeon to him.”
In addition to his scholarly and skillful pursuits, Dr. Boyne has endowed scholarship programs at Loma Linda University and Colby College to fund resident support and student tuition. Dr. Boyne passed away in June 2008.